Cargando…

Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient

BACKGROUND: Atypical fibroxanthoma (AFX) is a tumor that commonly presents on the head or neck in older individuals. Making a definitive diagnosis of AFX is challenging, and frequently, it is hard to distinguish from pleomorphic dermal sarcoma (PDS). There are no clear recommendations regarding the...

Descripción completa

Detalles Bibliográficos
Autores principales: Crimini, Edoardo, Roberto, Michela, Degli Effetti, Valter, Marchetti, Paolo, Botticelli, Andrea, Schipilliti, Francesca Matilde, Arrivi, Giulia, Mazzuca, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458881/
https://www.ncbi.nlm.nih.gov/pubmed/31049235
http://dx.doi.org/10.1155/2019/2507642
_version_ 1783410104965529600
author Crimini, Edoardo
Roberto, Michela
Degli Effetti, Valter
Marchetti, Paolo
Botticelli, Andrea
Schipilliti, Francesca Matilde
Arrivi, Giulia
Mazzuca, Federica
author_facet Crimini, Edoardo
Roberto, Michela
Degli Effetti, Valter
Marchetti, Paolo
Botticelli, Andrea
Schipilliti, Francesca Matilde
Arrivi, Giulia
Mazzuca, Federica
author_sort Crimini, Edoardo
collection PubMed
description BACKGROUND: Atypical fibroxanthoma (AFX) is a tumor that commonly presents on the head or neck in older individuals. Making a definitive diagnosis of AFX is challenging, and frequently, it is hard to distinguish from pleomorphic dermal sarcoma (PDS). There are no clear recommendations regarding the treatment of AFX, but an extensive surgery is actually considered the best option. Electrochemotherapy (ECT) is a novel therapeutic modality of local treatment in which the application of electrical pulses, enhancing cell membrane permeability, allows greater intracellular accumulation of chemotherapy drugs in the skin or subcutaneous tumors. CASE REPORT: We report a case of a 78-year-old male affected by a red, ulcerative, dermal, scalp nodule, which was treated with ECT with a complete clinical response. We have also reported literature data on this topic. RESULTS: In this case, ECT showed to be an effective and safe treatment for recurrent neoplasms of the head and neck, considering the complete response obtained and the absence of disease relapse after two years. CONCLUSION: To the best of our knowledge, this is the first case report that shows great clinical results using ECT after surgery in relapsed AFX/PDS. However, more studies are needed to confirm our results.
format Online
Article
Text
id pubmed-6458881
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-64588812019-05-02 Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient Crimini, Edoardo Roberto, Michela Degli Effetti, Valter Marchetti, Paolo Botticelli, Andrea Schipilliti, Francesca Matilde Arrivi, Giulia Mazzuca, Federica Case Rep Oncol Med Case Report BACKGROUND: Atypical fibroxanthoma (AFX) is a tumor that commonly presents on the head or neck in older individuals. Making a definitive diagnosis of AFX is challenging, and frequently, it is hard to distinguish from pleomorphic dermal sarcoma (PDS). There are no clear recommendations regarding the treatment of AFX, but an extensive surgery is actually considered the best option. Electrochemotherapy (ECT) is a novel therapeutic modality of local treatment in which the application of electrical pulses, enhancing cell membrane permeability, allows greater intracellular accumulation of chemotherapy drugs in the skin or subcutaneous tumors. CASE REPORT: We report a case of a 78-year-old male affected by a red, ulcerative, dermal, scalp nodule, which was treated with ECT with a complete clinical response. We have also reported literature data on this topic. RESULTS: In this case, ECT showed to be an effective and safe treatment for recurrent neoplasms of the head and neck, considering the complete response obtained and the absence of disease relapse after two years. CONCLUSION: To the best of our knowledge, this is the first case report that shows great clinical results using ECT after surgery in relapsed AFX/PDS. However, more studies are needed to confirm our results. Hindawi 2019-03-28 /pmc/articles/PMC6458881/ /pubmed/31049235 http://dx.doi.org/10.1155/2019/2507642 Text en Copyright © 2019 Edoardo Crimini et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Crimini, Edoardo
Roberto, Michela
Degli Effetti, Valter
Marchetti, Paolo
Botticelli, Andrea
Schipilliti, Francesca Matilde
Arrivi, Giulia
Mazzuca, Federica
Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient
title Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient
title_full Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient
title_fullStr Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient
title_full_unstemmed Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient
title_short Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient
title_sort electrochemotherapy as promising treatment option in rare recurrent cutaneous neoplasm of the scalp: case report of an elderly patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458881/
https://www.ncbi.nlm.nih.gov/pubmed/31049235
http://dx.doi.org/10.1155/2019/2507642
work_keys_str_mv AT criminiedoardo electrochemotherapyaspromisingtreatmentoptioninrarerecurrentcutaneousneoplasmofthescalpcasereportofanelderlypatient
AT robertomichela electrochemotherapyaspromisingtreatmentoptioninrarerecurrentcutaneousneoplasmofthescalpcasereportofanelderlypatient
AT deglieffettivalter electrochemotherapyaspromisingtreatmentoptioninrarerecurrentcutaneousneoplasmofthescalpcasereportofanelderlypatient
AT marchettipaolo electrochemotherapyaspromisingtreatmentoptioninrarerecurrentcutaneousneoplasmofthescalpcasereportofanelderlypatient
AT botticelliandrea electrochemotherapyaspromisingtreatmentoptioninrarerecurrentcutaneousneoplasmofthescalpcasereportofanelderlypatient
AT schipillitifrancescamatilde electrochemotherapyaspromisingtreatmentoptioninrarerecurrentcutaneousneoplasmofthescalpcasereportofanelderlypatient
AT arrivigiulia electrochemotherapyaspromisingtreatmentoptioninrarerecurrentcutaneousneoplasmofthescalpcasereportofanelderlypatient
AT mazzucafederica electrochemotherapyaspromisingtreatmentoptioninrarerecurrentcutaneousneoplasmofthescalpcasereportofanelderlypatient